A chilling revelation has surfaced regarding a former CDC official and the handling of COVID-19 vaccine directives. Susan Monarez, appointed to the CDC by Robert F. Kennedy Jr., privately signaled to health officials her willingness to contradict her own superior’s decisions.
The core of the controversy centers on Monarez’s initial support for widespread vaccination of children. This stance is now under intense scrutiny following the release of a leaked FDA memo. The memo details at least ten reported deaths in children potentially linked to the COVID-19 vaccines.
What began as dismissed “conspiracy theories” are now being quietly confirmed by mainstream media outlets. Recent reporting corroborates claims about the reasons behind Monarez’s dismissal, painting a picture of internal discord and conflicting priorities within the CDC.
The timeline is stark: a claim initially labeled as unfounded gained confirmation within a little over three months. This rapid shift from speculation to verified information raises serious questions about transparency and the speed at which critical data was initially assessed.
The implications of these revelations extend beyond a single personnel matter. They force a re-examination of the initial push for pediatric vaccination and the processes used to evaluate vaccine safety signals. The unfolding story demands a deeper understanding of the internal pressures and decision-making processes within public health agencies.
